Testimony

TESTIMONY

Preparing and presenting public or written testimony to legislative committees or regulatory boards is one way for our physicians and pharmacists to share their expertise in the delivery of community cancer care and protecting the patient-physician relationship. The US Oncology Network along with physicians and pharmacists within The Network have provided verbal and written testimony on important legislative and regulatory matters important to community cancer care across the US. 

Barry Brooks, MD, with Texas Oncology, testifies before the Energy and Commerce Health Subcommittee Hearing on Keeping the Promise: Site of Service Medicare Payment Reforms.

May 21, 2014. 

Debra Patt, MD, with Texas Oncology, testifies before the Energy and Commerce Health Subcommittee Hearing on The Obama Administration’s Medicare Drug Experiment: The Patient and Doctor Perspective. 

May 17, 2016. 

Debra Patt, MD, with Texas Oncology testifies before the Energy and Commerce Health Subcommittee Hearing on Opportunities to Improve the 340B Drug Pricing Program. 


July 11, 2018.

Debra Patt, MD, with Texas Oncology, testifies before the Texas House Insurance Committee on How Prior Authorization Costs Patients Time & Money. 

March 9, 2021. 

Randy Drosick, MD, with OHC Specialists in Cancer and Blood Disorders in Ohio, testifies before the Ohio House Insurance Committee in support for HB 451: Revising the Physician Administered Drug Law. 

February 9, 2022.